C$7.6 0.0 0.0%
Last Trade - 14/04/21
Market Cap | £57.1m |
Enterprise Value | £43.2m |
Revenue | £13.0m |
Position in Universe | 874th / 2712 |
Nov 26 (Reuters) - Biosyent Inc RX.V : * BIOSYENT RELEASES FINANCIAL RESULTS FOR THIRD QUARTER AND FIRST NINE MONTHS OF 2020 * Q3 EARNINGS PER SHARE C$0.07 * Q3 REVENUE FELL 7 PERCENT TO C$5.772 MILLION Source text for Eikon: ID:nGNX1CbyJt Further company coverage: RX.V ((Reuters.Briefs@thomsonreuters.com;))